BioVie (BIVI) News Today → World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad) Free BIVI Stock Alerts $0.49 -0.02 (-3.93%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBioVie Presents Data Showing Potential for Bezisterim (NE3107) to Reduce Inflammation and Restore Homeostasis in a Manner Correlated with Alzheimer’s Disease and Biomarker Endpointsfinance.yahoo.com - April 25 at 9:37 AMBioVie presents new data showing lead drug asset may promote healthier agingproactiveinvestors.com - April 25 at 9:26 AMBioVie Presents Data Showing Potential for Bezisterim (NE3107) to Reduce Inflammation and Restore Homeostasis in a Manner Correlated with Alzheimer's Disease and Biomarker Endpointsglobenewswire.com - April 25 at 8:00 AMBioVie (BIVI) to Release Earnings on Mondayamericanbankingnews.com - April 21 at 2:24 AMLatest News for BioVie Stock (NASDAQ:BIVI)benzinga.com - April 19 at 3:48 PMBioVie to Present Data Showing How NE3107 Potentially Restores Homeostasis via Specific Genes Associated with Dementia, Metabolism, and Inflammationglobenewswire.com - April 18 at 8:00 AMSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioVie Inc. of Class Action Lawsuit and Upcoming Deadlines - BIVIprnewswire.com - March 19 at 4:00 PMThe Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against BioVie Inc. (BIVI)businesswire.com - March 18 at 12:00 PMDEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioViestockhouse.com - March 17 at 10:43 AMINVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioViestockhouse.com - March 16 at 12:39 PMBIVI Oct 2024 1.500 putca.finance.yahoo.com - March 16 at 2:38 AMBIVI Apr 2024 5.000 putfinance.yahoo.com - March 15 at 9:33 PMBIVI Jul 2024 3.500 putfinance.yahoo.com - March 15 at 9:33 PMShareholders that lost money on BioVie Inc.(BIVI) should contact Levi & Korsinsky about pending Class Action - BIVIprnewswire.com - March 15 at 5:45 AMThe Gross Law Firm Notifies Shareholders of BioVie Inc. (BIVI) of a Class Action Lawsuit and an Upcoming Deadlineprnewswire.com - March 14 at 5:45 AM4-DAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in BioVie Inc. with Losses of $100,000 to Contact the Firmstockhouse.com - March 14 at 1:45 AMBIVI Investors Have Opportunity to Lead BioVie Inc. Securities Fraud Lawsuitprnewswire.com - March 13 at 2:15 PMClass Action Filed Against BioVie Inc. (BIVI) - March 19, 2024 Deadline to Join - Contact Levi & Korsinskyprnewswire.com - March 12 at 5:45 AMBioVie to kick off Phase 2b trial for lead asset in Parkinson's disease in late-summerproactiveinvestors.com - March 11 at 8:56 AMBioVie Announces Pipeline Update and Near-Term Clinical Prioritiesglobenewswire.com - March 11 at 8:00 AMBioVie Inc. Class Action: The Gross Law Firm Reminds BioVie Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024 - BIVIprnewswire.com - March 11 at 5:45 AMSHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioViestockhouse.com - March 9 at 3:18 PMBIOVIE INVESTOR ALERT: Kirby McInerney LLP Alerts BioVie, Inc. (BIVI) Investors of Looming Lead Plaintiff Deadline in Class Action Lawsuitmarkets.businessinsider.com - March 8 at 7:27 PMContact The Gross Law Firm by March 19, 2024 Deadline to Join Class Action Against BioVie Inc.(BIVI)prnewswire.com - March 7 at 5:45 AMATTENTION BIOVIE INC. Shareholders: Securities Fraud Lawsuit Filed Against BioVie Inc. (BIVI)markets.businessinsider.com - March 7 at 2:22 AMBioVie Inc. Announces Closing of Public Offeringglobenewswire.com - March 6 at 5:00 PMContact Levi & Korsinsky by March 19, 2024 Deadline to Join Class Action Against BioVie Inc.(BIVI)prnewswire.com - March 6 at 5:45 AMBIVI Apr 2024 1.500 putfinance.yahoo.com - March 4 at 7:55 PMBIVI Oct 2024 0.500 putfinance.yahoo.com - March 4 at 7:55 PMBioVie Announces Pricing Of Its Best Efforts Public Offering - Quick Factsmarkets.businessinsider.com - March 4 at 2:54 PMWhy BioVie (BIVI) Shares Are Down 40%msn.com - March 4 at 2:54 PMWhy Is BioVie (BIVI) Stock Down 41% Today?investorplace.com - March 4 at 9:12 AMWhy Is BioVie (BIVI) Stock Down 41% Today?investorplace.com - March 4 at 8:51 AMBioVie slumps 18%, prices $21M equity offeringmsn.com - March 4 at 8:13 AMBIOVIE INC. (BIVI) INVESTOR ALERT: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Actionmarkets.businessinsider.com - March 4 at 8:13 AMBioVie Inc. Announces Pricing of Public Offeringglobenewswire.com - March 4 at 1:32 AMBIVI Mar 2024 2.500 callfinance.yahoo.com - March 3 at 10:19 PMSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioVie Inc. of Class Action Lawsuit and Upcoming Deadlines - BIVIprnewswire.com - March 3 at 10:00 AMWhy Is Alzheimer's/Parkinson's Focused BioVie Stock Surging On Friday?msn.com - March 1 at 9:35 PMBioVie Inc. Announces Proposed Public Offering of Common Stocglobenewswire.com - March 1 at 4:58 PMBioVie Sees Unusually High Options Volume (NASDAQ:BIVI)marketbeat.com - March 1 at 4:18 PMBioVie jumps as Alzheimer’s drug selected for presentationsmsn.com - March 1 at 11:30 AMWhy Is BioVie (BIVI) Stock Up 100% Today?investorplace.com - March 1 at 10:57 AMBioVie shares surge on lead asset NE3107's potential to improve Parkinson's Disease symptomsproactiveinvestors.com - March 1 at 9:49 AMBioVie's NE3107 Demonstrates Potential Improvements in Motor and Non-motor Symptoms for Parkinson's Disease Patients and May Be Realigning Physiological Processes for Alzheimer's Patients in Data to be Presented at the International Conference on Alzheimer's and Parkinson's Diseases 2024globenewswire.com - March 1 at 8:00 AMSHAREHOLDER ALERT: Potential Recovery for BioVie Inc. (BIVI) Investorsmsn.com - February 29 at 10:42 PMSHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioVieprnewswire.com - February 29 at 11:45 AMBioVie Deadline Alertstockhouse.com - February 28 at 9:58 AMINVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in BioVie Inc. with Losses of $100,000 to Contact the Firmstockhouse.com - February 27 at 2:11 PMBioVie Deadline Reminderstockhouse.com - February 27 at 8:50 AM Get BioVie News Delivered to You Automatically Sign up to receive the latest news and ratings for BIVI and its competitors with MarketBeat's FREE daily newsletter. Email Address The Gold Grab of the Century (Ad)When central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago. That's why we have released our Free Precious Metals Investment Guide. BIVI Media Mentions By Week BIVI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIVI News Sentiment▼0.340.38▲Average Medical News Sentiment BIVI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIVI Articles This Week▼73▲BIVI Articles Average Week Get BioVie News Delivered to You Automatically Sign up to receive the latest news and ratings for BIVI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Flora Growth News Today KALA BIO News Today FSD Pharma News Today RenovoRx News Today Vincerx Pharma News Today Lumos Pharma News Today Galecto News Today Onconova Therapeutics News Today Synlogic News Today MEI Pharma News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BIVI) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsYour Money is Not SafeAmerican AlternativeFed launches fourth dollar overhaulStansberry ResearchThe World's First "$20 Trillion Drug?"Behind the MarketsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsI’m afraid WWIII is a very real possibility Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioVie Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
